SCHEMBL19924243

SCHEMBL19924243

CCCC[C@H](CNC(C)=O)Nc1nc(NCc2ccc(OC)cc2OC)nc2ccsc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4A P27815 3/20 0.43
▸ PDE4B Q07343 3/20 0.43
▸ PDE4C Q08493 3/20 0.43
▸ PDE4D Q08499 3/20 0.43
▸ PDE3B Q13370 3/20 0.43
▸ PDE3A Q14432 3/20 0.43
▸ FLT3 P36888 1/20 0.40
▸ TYRO3 Q06418 1/20 0.40
▸ MERTK Q12866 1/20 0.40
▸ GAS6 Q14393 1/20 0.40
▸ CNR1 P21554 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ KCNH2 Q12809 2/20 0.38
▸ MAOB P27338 1/20 0.38
▸ MAPT P10636 3/20 0.37
▸ THRB P10828 1/20 0.37
▸ ADORA2B P29275 4/20 0.37
▸ ADORA2A P29274 3/20 0.37
▸ POLB P06746 1/20 0.37
▸ MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924245 1.00 PDE4A (0.43) PDE4APDE4BPDE4CPDE4DPDE3B
SCHEMBL19924284 0.86 CYP1A2 (0.48) KCNH2MAPTTHRBMEN1TSHR
SCHEMBL30076248 0.86 CYP1A2 (0.48) KCNH2MAPTTHRBMEN1TSHR
SCHEMBL19924285 0.86 CYP1A2 (0.48) KCNH2MAPTTHRBMEN1TSHR
SCHEMBL19924247 0.85 KCNH2 (0.42) FLT3TYRO3MERTKGAS6CNR1
SCHEMBL19924246 0.85 KCNH2 (0.42) FLT3TYRO3MERTKGAS6CNR1
SCHEMBL18109450 0.84 TLR8 (0.44) FLT3TYRO3MERTKGAS6CNR1
SCHEMBL19924193 0.84 KCNH2 (0.46) FLT3TYRO3MERTKGAS6CNR1
SCHEMBL18109452 0.84 TLR8 (0.44) FLT3TYRO3MERTKGAS6CNR1
SCHEMBL19924192 0.84 KCNH2 (0.46) FLT3TYRO3MERTKGAS6CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12522570-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2026-01-13 — — US disclosed
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2024-08-01 — — US disclosed
US-11827609-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2023-11-28 — — US disclosed
US-11827609-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2023-11-28 — — US disclosed
US-20220073473-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2022-03-10 — — US disclosed
EP-3507276-B1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-11-03 — — EP disclosed
EP-3507276-B1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES INC (US) 2021-11-03 — — EP disclosed
US-11124487-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2021-09-21 — — US disclosed
US-11124487-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2021-09-21 — — US disclosed
US-10370342-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2019-08-06 — — US disclosed
US-10370342-B2 Toll like receptor modulator compounds GILEAD SCIENCES, INC. (US) 2019-08-06 — — US disclosed
WO-2018045144-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. (US) 2018-03-08 — — WO disclosed
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2018-03-08 — — US disclosed
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS GILEAD SCIENCES, INC. 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073473-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885
US-10370342-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885
US-11124487-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885
US-20240254091-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885
US-20180065938-A1 TOLL LIKE RECEPTOR MODULATOR COMPOUNDS TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885
US-11827609-B2 Toll like receptor modulator compounds TLR8, TLR3, TLR6 PDE4A 510/4885PDE4B 774/4885PDE4C 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback